REQUEST A DEMO
Total
USD $0.00
Search more companies

Ever Pharma Poland Sp. z o.o. (Poland)

Main Activities: Administrative Management and General Management Consulting Services
Full name: Ever Pharma Poland Sp. z o.o. Profile Updated: September 12, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Ever Pharma Poland Sp. z o.o. is an enterprise located in Poland, with the main office in Warsaw. The company operates in the Administrative Management and General Management Consulting Services sector. It was established on July 13, 2018. The company’s latest financial report indicates a net sales revenue increase of 14.79% in 2023. Its’ total assets recorded a growth of 31%. The net profit margin of Ever Pharma Poland Sp. z o.o. decreased by 1.04% in 2023.

Headquarters
Ul. Barcicka 45/1
Warsaw; Mazowieckie; Postal Code: 01-839

Contact Details: Purchase the Ever Pharma Poland Sp. z o.o. report to view the information.

Website: http://www.everpharma.com/pl

Basic Information
Outstanding Shares:
Purchase the Ever Pharma Poland Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Ever Pharma Poland Sp. z o.o. report to view the information.
Incorporation Date:
July 13, 2018
Key Executives
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Ever Pharma Poland Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
14.79%
Total operating revenue
14.79%
Operating profit (EBIT)
14.42%
EBITDA
19.93%
Net Profit (Loss) for the Period
-18.54%
Total assets
31%
Total equity
21.35%
Operating Profit Margin (ROS)
-0.01%
Net Profit Margin
-1.04%
Return on Equity (ROE)
-8.62%
Quick Ratio
-0.4%
Cash Ratio
0.2%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?